Carfì et al. observed persistent inflammatory markers in patients recovering from acute COVID-19, suggesting a role for NF-κB in sustaining inflammation and potentially contributing to the development of PASC.478 These studies suggested that NF-κB activation during this stage may contribute to chronic inflammation and immune dysregulation, influencing the extended duration and severity of symptoms. The gene discussed is NFKB1; the disease is COVID-19.